682
SAFAEI-GHOMI and GHASEMZADEH
DMSO-d , δ / ppm): 2.03 (3H, s, CH ), 4.86 (1H, d, J = 5.0 Hz, 4–CH) 5.14 (1H,
6
3
d, J = 5.0 Hz, 5–CH), 6.87–7.29 (9H, m, Ar–H), 8.85 (1H, bs, NH), 9.64 (1H, bs,
13
NH). C-NMR (100 MHz, DMSO-d , δ / ppm): 21.2, 56.0, 102.8, 127.4, 127.9,
6
128.5, 129.5, 130.4, 130.7, 134.9, 138.4, 142.2, 178.1.
4-(2-Methoxyphenyl)-6-phenyl-3,4-dihydropyrimidine-2(1H)-thione (3e). White
crystals; m.p.: 178–180°C; Anal. Calcd. for C H N OS: C 68.91, H 5.40, N
17 16
2
–1
9.45 %. Found: C 68.99, H 5.50, N 9.39 %. FTIR (KBr, cm ): 3152 (NH ), 1642
(C=N), 1555, 1479 (C=C), 1182 (C=S). H-NMR (400 MHz, DMSO-d , δ / ppm):
3.60 (3H, s, –OCH ), 5.13 (2H, m, 4–CH, 5–CH), 6.93–7.23 (9H, m, Ar–H), 8.75
(1H, bs, NH), 9.71 (1H, bs, NH). C-NMR (100 MHz, DMSO-d , δ / ppm):
50.2, 56.0, 100.8, 111.5, 121.1, 126.2, 126.9, 128.8, 129.1, 129.2, 132.1, 133.8,
1
6
3
13
6
+
134.8, 155.73, 177.3. MS (EI) (m/z): 296 (M ).
4-(4-Methoxyphenyl)-6-phenyl-3,4-dihydropyrimidine-2(1H)-thione (3f). White
19
–1
crystals; m.p.: 123–125 C (lit. m.p. 123–124 °C). FTIR (KBr, cm ): 3149 (NH),
1
1642 (C=N), 1555, 1479 (C=C), 1182 (C=S). H-NMR (400 MHz, DMSO-d , δ /
/ ppm): 3.60 (3H, s, –OCH ), 5.13 (2H, m, 4–CH, 5–CH), 6.79–7.25 (9H, m, Ar–H),
8.62 (1H, bs, NH), 9.60 (1H, bs, NH). C-NMR (100 MHz, DMSO-d , δ / ppm):
50.2, 56.0, 100.8, 111.6, 121.1, 126.2, 128.8, 129.1, 129.2, 132.1, 134.8, 155.8,
178.2.
6
3
13
6
4-(2,4-Dimethoxyphenyl)-6-phenyl-3,4-dihydropyrimidine-2(1H)-thione (3g).
White crystals; m.p.: 180–182 °C. Anal. Calcd. for C H N O S: C 66.25, H
18 18
2 2
–1
5.52, N 8.58 %. Found: C 66.29, H 5.43, N 8.67 %. FTIR (KBr, cm ): 3195
(NH), 1644 (C=N), 1581, 1465 (C=C), 1162 (C=S). H-NMR (400 MHz, DMSO-
1
-d , δ / ppm): 3.60 (6H, s, 2’,4’–OCH ), 5.13 (2H, m, 4–CH, 5–CH), 6.83–7.25
6
3
13
(8H, m, Ar–H), 8.60 (1H, bs, NH), 9.63 (1H, bs, NH). C-NMR (100 MHz,
DMSO-d , δ / ppm): 51.1, 58.2, 101.2, 111.2, 121.2, 125.2, 125.9, 127.3, 129.1,
6
+
129.8, 132.6, 134.8, 153.7, 154.6, 177.1. MS (EI) (m/z): 326 (M ).
4-(4-N,N-Dimethylphenyl)-6-phenyl-3,4-dihydropyrimidine-2(1H)-thione (3h).
Yellow crystals; m.p.: 162–164 °C; Anal. Calcd. for C H N S: C 69.91, H
18 19
3
–1
6.14, N 13.9 %. Found: C 70.03, H 6.19, N 13.95 %. FTIR (KBr, cm ): 3196
(NH), 1640 (C=N), 1552, 1475 (C=C), 1191 (C=S). H-NMR (400 MHz, DMSO-
1
-d , δ / ppm): 2.74 (6H, s, N(Me) ), 5.00 (2H, m, 4–CH, 5–CH), 6.83–7.25 (8H, m,
6
2
13
Ar–H), 8.64 (1H, bs, NH), 9.60 (1H, bs, NH). C-NMR (100 MHz, DMSO-d , δ /
/ppm): 56.5, 79.7, 102.0, 112.2, 125.6, 126.3, 128.0, 128.2, 130.3, 134.5, 138.7,
150.5, 176.1. MS (m/z): 309 (M ).
6
+
In the present work, chalcone derivatives 1 were treated with thiourea 2 in
the presence of potassium hydroxide in ethanol to produce the pyrimidine-2-thi-
one derivatives 3. The reaction occurred in two steps: first conjugate addition
took place on the β-position of carbonyl group and then nucleophilic attack on
the carbonyl group followed by dehydration led to the six-membered ring pro-
17,19,20
ducts (Scheme 1).
____________________________________A__v_a__i_la__b__le___o_n__l_in__e__a__t__w__w__w__._s_h__d__.o__r_g__.r__s_/_J_S_C__S__/____________________________________
2011 Copyright (CC) SCS